Evidence map›Paper›PMID 41672735›Full record

ArticleLife science alliance2026

Structural and functional characterisation of ATF2 nuclear import reveals paralogue-selective importin-α recognition and a non-canonical NLS formed in trans.

Seyed Mohammad Ghafoori, Silvia Pavan, Trinh Xuan Duc, Sepehr Nematollahzadeh, Gayle F Petersen, Gualtiero Alvisi, Jade K Forwood

Abstract read
In one paragraph

Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seyed Mohammad GhafooriSchool of Life and Environmental Sciences, University of Sydney, Sydney, Australia.
Silvia PavanDepartment of Molecular Medicine, University of Padova, Padova, Italy.
Trinh Xuan DucDepartment of Molecular Medicine, University of Padova, Padova, Italy.ORCID 0009-0005-7594-7180
Sepehr NematollahzadehDepartment of Molecular Medicine, University of Padova, Padova, Italy.
Gayle F PetersenGulbali Institute, Charles Sturt University, Wagga Wagga, Australia.ORCID 0000-0003-3666-0150
Gualtiero AlvisiDepartment of Molecular Medicine, University of Padova, Padova, Italy.ORCID 0000-0002-8177-3616
Jade K ForwoodSchool of Agricultural, Environmental and Veterinary Sciences, Faculty of Science and Health, Charles Sturt University, Wagga Wagga, Australia jforwood@csu.edu.au.ORCID 0000-0003-3267-9997

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activating transcription factor 2 (ATF2) is a member of the AP-1 superfamily that regulates essential cellular processes through its activity as a nuclear transcription factor. Although ATF2 plays well-established roles in neurodevelopment, inflammation, and cancer, the mechanisms underlying its nuclear localisation remain poorly characterised. Here, we investigate the structural and functional basis of ATF2 nuclear import via the classical importin-α/β1 (IMPα/β1) pathway. Using quantitative in vitro binding assays, we demonstrate that ATF2 interacts with multiple IMPα paralogues. Fluorescence polarisation measurements reveal the highest binding affinity for IMPα1, with progressively weaker interactions observed for IMPα3, IMPα5, and IMPα7. Crystallographic analysis of ATF2 bound to IMPα1 identifies two basic clusters that are important for interaction: site 1 (

Indexed as

Activating Transcription Factor 2alpha KaryopherinsNuclear Localization SignalsActive Transport, Cell NucleusBinding SitesCell NucleusHEK293 CellsHumansProtein BindingActivating Transcription Factor 2alpha KaryopherinsATF2 protein, humanNuclear Localization Signals

Identifiers

PMID41672735
PMCPMC12894764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.